网站主页>>>项目整合精选>>>项目整合精选>>>新产品编号:2280171

新产品编号:2280171

Chemical Name: 7-[4-[6-(2-Chlorophenyl)-1,4-dimethyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-9-ylmethyl]phenyl]-7-(3-pyridyl)-6(E/Z)-heptenoic acid ethyl ester
项目整合开发状态: Preclinical
项目研究机构: Nikken Chemicals (Originator)
合成路线:Ketone (I) was converted to the corresponding oxime (II) by treatment with hydroxylamine hydrochloride and pyridine.Subsequent alkylation of the oxime (II) with ethyl 5-bromovalerate (III) in the presence of NaH provided (IV).After desilylation of (IV) by means of tetrabutylammonium fluoride,the liberated alcohol (V) was converted to mesylate (VI).The title compound was then obtained by condensation of mesylate (VI) with the pyridothienotriazolodiazepine derivative (VII).

合成路线:The Wittig condensation of 1-[4-(tert-butyldiphenylsilyloxymethyl)phenyl]-1-(3-pyridyl)methanone (I) with phosphonium bromide (II) by means of NaH in tert-butanol gives the heptenoic ester (III),which is desilylated with TBAF in THF to yield 7-[4-(hydroxymethyl)phenyl]-7-(3-pyridyl)-6-heptenoic acid ethyl ester (IV).The reaction of (IV) with Ms-Cl and TEA affords the corresponding mesylate (V),which is finally condensed with the triazolodiazepine (VI) by means of K2CO3 and 18-crown-6 in DMF.

合成路线:Treatment of 4-(t-butyldiphenylsilyloxymethyl)phenyl-(3-pyridyl)ketone (I) with hydroxylamine hydrochloride in pyridine affords oxime (II) as a mixture of geometric isomers.Then,alkylation of oxime (II) with ethyl 5-bromovalerate (III) in the presence of NaH provides ester (IV).After desilylation of (IV) with tetrabutylammonium fluoride,the deprotected primary alcohol (V) is oxidized by KMnO4 to furnish carboxylic acid (VI).Finally,DCC-mediated coupling of acid (VI) with the known tetracyclic precursor (VII) gives rise to the corresponding amide.
📌 参考资料/链接:
参考文献标题:Triazolo-1,4-diazepine cpds.and medicinal compsn.containing the same
文献作者:Sano,T.; Seki,T.; Fujita,M.; Inada,H.(Nikken Chemicals Co.,Ltd.)
参考来源:EP 0995752; JP 1999071378; US 6433167; WO 9858930

📄 详细内容


合成路线:The Wittig condensation of 1-[4-(tert-butyldiphenylsilyloxymethyl)phenyl]-1-(3-pyridyl)methanone (I) with phosphonium bromide (II) by means of NaH in tert-butanol gives the heptenoic ester (III),which is desilylated with TBAF in THF to yield 7-[4-(hydroxymethyl)phenyl]-7-(3-pyridyl)-6-heptenoic acid ethyl ester (IV).The reaction of (IV) with Ms-Cl and TEA affords the corresponding mesylate (V),which is finally condensed with the triazolodiazepine (VI) by means of K2CO3 and 18-crown-6 in DMF.
参考文献标题:Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI)
文献作者:Fujita,M.; Seki,T.; Inada,H.; Shimizu,K.; Takahama,A.; Sano,T.
参考来源:Bioorg Med Chem Lett 2002,12(5),771